Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GLP-1/GIP/glucagon receptor triagonism gets its try in humans
Brian Finan, Jonathan D. Douros
Cell Metabolism (2022) Vol. 34, Iss. 1, pp. 3-4
Open Access | Times Cited: 9

Showing 9 citing articles:

Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
Katherine O. Kopp, Elliot J. Glotfelty, Yazhou Li, et al.
Pharmacological Research (2022) Vol. 186, pp. 106550-106550
Open Access | Times Cited: 114
Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity
Isabella Zaffina, Maria Chiara Pelle, Giuseppe Armentaro, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 18
The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue
Samrin Kagdi, Sulayman A. Lyons, Jacqueline L. Beaudry
Journal of Endocrinology (2024) Vol. 261, Iss. 3
Open Access | Times Cited: 6
Focus on Glucagon-like Peptide-1 Target: Drugs Approved or Designed to Treat Obesity
Jiahua Zhang, Jintao Wei, Weiwen Lai, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1651-1651
Open Access
A Case of Severe Cholestatic Hepatitis Induced by a Novel Dual Agonist of Glucagon-like Peptide-1 and Glucose-dependent Insulinotropic Polypeptide Receptors
Junmin Jiang, Meifeng Shi, Shuduo Wu, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 1
Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis, and the Heart
Jean‐Philippe Krieger, Derek Daniels, Shin Lee, et al.
Comprehensive physiology (2024) Vol. 15, Iss. 1
Closed Access | Times Cited: 1
Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
Shubham Vishnoi, Shayon Bhattacharya, Erica M. Walsh, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 15, pp. 4934-4947
Open Access | Times Cited: 3
Discovery of a Novel Glucagon-like Peptide-1 (GLP-1) Analogue from Bullfrog and Investigation of Its Potential for Designing GLP-1-Based Multiagonists
Neng Jiang, Di Su, De Chen, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 180-198
Closed Access | Times Cited: 2
Glucose-Dependent Insulinotropic Polypeptide and Substance P Mediate Emetic Response Induction by Masked Trichothecene Deoxynivalenol-3-Glucoside through Ca2+ Signaling
Zihui Qin, Hua Zhang, Qinghua Wu, et al.
Toxins (2022) Vol. 14, Iss. 6, pp. 371-371
Open Access | Times Cited: 2
Page 1

Scroll to top